December 22, 2005
ENTREMED TO ACQUIRE MIIKANA THERAPEUTICS

December 13, 2005
ALEXZA PHARMACEUTICALS EXPANDS EXECUTIVE MANAGEMENT TEAM

December 8, 2005
AMBRX AND ROCHE ENTER INTO BROAD TECHNOLOGY COLLABORATION

October 13, 2005
KALYPSYS EXPANDS ITS SYSTEMS BUSINESS PRODUCT PORTFOLIO

September 20, 2005
AMBRX APPOINTS MARTIN A. MATTINGLY AS CEO AND PRESIDENT

September 7, 2005
GENOSPECTRA APPOINTS GEORGE E. BERS EXECUTIVE VICE PRESIDENT, COMMERCIAL OPERATIONS

August 24, 2005
KALYPSYS ANNOUNCES KEY APPOINTMENT - DR. PAUL GRINT AS CHIEF MEDICAL OFFICER

July 19, 2005
ILYPSA RAISES $36 MILLION IN SERIES B PRIVATE FINANCING FUNDS TO SUPPORT THE CLINICAL ADVANCEMENT OF LEAD COMPOUNDS

June 21, 2005
AMBRX AND IKARIA MAKE FIERCEBIOTECH'S FIERCE 15 LIST FOR 2005

June 16, 2005
KALYPSYS AND NOVIMMUNE ESTABLISH COLLABORATION FOR DISCOVERY AND DEVELOPMENT OF NEW DRUGS FOR AUTOIMMUNE AND INFLAMMATORY DISEASES

June 15, 2005
KALYPSYS TO PROVIDE THE FLORIDA SCRIPPS RESEARCH INSTITUTE WITH NEXT-GENERATION LEAD DISCOVERY TECHNOLOGY

June 1, 2005
SCIENTIFIC AMERICAN - IKARIA: BUYING TIME IN SUSPENDED ANIMATION

May 9, 2005
BIOCENTURY - MIIKANA: PLUCKING FROM PHARMA

May 3, 2005
MIIKANA THERAPEUTICS LICENSES PHASE II CLINICAL ANTI-CANCER COMPOUND FROM ROCHE

April 26, 2005
NEW YORK TIMES ARTICLE (IKARIA): HIBERNATING MICE MAY SOMEDAY SAVE HUMANS

April 25, 2005
IKARIA LAUNCHED BY ARCH VENTURE PARTNERS, VENROCK ASSOCIATES, 5AM VENTURES AND FRED HUTCHINSON CANCER RESEARCH CENTER

April 23, 2005
WALL STREET JOURNAL ARTICLE (IKARIA): RESEARCHERS TRIGGER HIBERNATION IN MICE: HINTS OF FUTURE USES

April 8, 2005
AMBRX COMPLETES $23.4 MILLION PRIVATE PLACEMENT

March 22, 2005
KALYPSYS ANNOUNCES APPOINTMENT OF CEO

March 16, 2005
KALOBIOS PHARMACEUTICALS RAISES $20 MILLION IN PRIVATE EQUITY, LED BY MPM CAPITAL AND GBS VENTURES

January 6, 2005
ALEXZA MDC RAISES $52 MILLION IN SERIES D FINANCING